ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer

• Enriqueta Felip,
• Solange Peters,
• Alfredo Addeo,
• Martin Reck,
• Antonio Passaro,
• Christophe Von Garnier,
• Fiona Blackhall,
• David Planchard,
• Rafal Dziadziuszko,
• Filippo de Marinis,
• Hasna Bouchaab

Affiliations

Enriqueta Felip

Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Solange Peters

Centre Hospitalier Universitaire Vaudois (CHUV), Department of Oncology, rue du Bugnon 46, CH-1011 Lausanne, Switzerland

Alfredo Addeo

Oncology, Hopitaux Universitaires de Geneve, Geneva, Switzerland

Martin Reck

LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany

Antonio Passaro

Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy

Christophe Von Garnier

Department of Pulmonary Medicine, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland

Fiona Blackhall

Division of Cancer Sciences, University of Manchester & The Christie NHS Foundation Trust, Manchester, UK

David Planchard

Department of Medical Oncology, Thoracic Unit, Gustave Roussy, Villejuif, France

Rafal Dziadziuszko

Department of Oncology and Radiotherapy, Gdanski Uniwersytet Medyczny, Gdansk, Poland

Filippo de Marinis

Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy

Hasna Bouchaab

Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland